Benchmark Holdings PLC
LSE:BMK
Benchmark Holdings PLC
Cash & Cash Equivalents
Benchmark Holdings PLC
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Benchmark Holdings PLC
LSE:BMK
|
Cash & Cash Equivalents
£13.8m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Nomad Foods Ltd
NYSE:NOMD
|
Cash & Cash Equivalents
€403m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Associated British Foods PLC
LSE:ABF
|
Cash & Cash Equivalents
£1.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
14%
|
|
|
Premier Foods PLC
LSE:PFD
|
Cash & Cash Equivalents
£113.9m
|
CAGR 3-Years
138%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Cranswick PLC
LSE:CWK
|
Cash & Cash Equivalents
£8.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-3%
|
|
|
Tate & Lyle PLC
LSE:TATE
|
Cash & Cash Equivalents
£594m
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
Benchmark Holdings PLC
Glance View
Benchmark Holdings Plc engages in the provision of applied biotechnology, sustainability research, and other related services to aquaculture, agriculture, and food sector. The company is headquartered in Sheffield, South Yorkshire and currently employs 796 full-time employees. The company went IPO on 2013-12-18. The Company’s segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with state-of-the-art production facilities to provide a range of genetic merit ova. Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The firm has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics and sea lice treatments.
See Also
What is Benchmark Holdings PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
13.8m
GBP
Based on the financial report for Dec 31, 2024, Benchmark Holdings PLC's Cash & Cash Equivalents amounts to 13.8m GBP.
What is Benchmark Holdings PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
-36%
Over the last year, the Cash & Cash Equivalents growth was -43%. The average annual Cash & Cash Equivalents growth rates for Benchmark Holdings PLC have been -36% over the past three years .
You don't have any saved screeners yet